ENTRY       D12416                      Drug
NAME        Petosemtamab (USAN/INN)
FORMULA     C6479H9972N1714O2040S46
EXACT_MASS  145899.6411
MOL_WEIGHT  145989.7528
SEQUENCE    (Heavy chain)
            EVQLVQSGSK LKKPGASVKV SCKASGYTFT SYTMNWVRQA PGQGLEWMGW INTDTGDPTY
            AQGFTGRFVF SLDTSVSTAF LQINSLKAED TAVYYCARGD CDSTSCYRYS YGYEDYWGQG
            TLVTVSSAST KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF
            PAVLQSSGLY SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKRVEPKSC DKTHTCPPCP
            APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK
            PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT
            KPPSREEMTK NQVSLKCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL
            TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSP
            (heavy chain)
            XVQLVQSGSE LKKPGASVKI SCKASGYDFT NYAMNWVRQA PGHGLEWMGW INANTGDPTY
            AQGFTGRFVF SLDTSVSTAY LQISSLKAED SAVYYCTRER FLEWLHFDYW GQGTLVTVSS
            ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKRVEP KSCDKTHTCP PCPAPELLGG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTDPPSREE
            MTKNQVSLTC EVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
            QQGNVFSCSV MHEALHNHYT QKSLSLSPG
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQSIS SYLNWYQQKP GKAPKLLIYA ASSLQSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ SYSTPPTFGQ GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN 	RGEC
            (Disulfide bridge: H22-H96, H101-H106, H154-H210, H230-L214, H236-h229, H239-h232, H271-H331, H377-H435, h22-h96, h147-h203, h223-L'214, h264-h324, h370-h428, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody, bispecific antibody
COMMENT     Treatment of cancer
TARGET      EGFR [HSA:1956] [KO:K04361]
            LGR5 [HSA:8549] [KO:K04308]
  PATHWAY   hsa04012(1956)  ErbB signaling pathway
            hsa04014(1956)  Ras signaling pathway
            hsa04310(8549)  Wnt signaling pathway
            hsa05200(1956)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               R-spondin
                LGR5
                 D12416  Petosemtamab (USAN/INN)
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                EGFR
                 D12416  Petosemtamab (USAN/INN)
DBLINKS     CAS: 2213450-26-9
///
